Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Recalls Duloxetine Antidepressant for Cancer Risk
Brownie Recall Update as FDA Sets Risk Level
The products were found to contain an undeclared allergen, which could be a risk for those with food allergies.
Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential Carcinogen
Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially cancer-causing chemicals. The recall was initiated on Nov. 19 by manufacturer Rising Pharma,
FDA Recalls Duloxetine Antidepressant for Cancer Risk: What to Know
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic pain. A recent Food and Drug Administration (FDA) recall of a commonly prescribed antidepressant,
Antidepressant Recall Update As FDA Sets Risk Level
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
FDA may take steps to ban red food dye
FDA red food dye ban: When it could happen, and what to know
The FDA is reviewing a petition that could ban an artificial food coloring called Red No. 3. Here’s what to know about the petition and the product.
Red food dye could soon be banned as FDA reviews petition: ‘Scary stuff’
The U.S. Food and Drug Administration is considering banning an artificial food coloring called Red No. 3 due to potential health risks, including a link to cancer.
Will the FDA act on health concerns over red dye 3 and ban the food additive?
Advocates have been calling for a ban of red dye 3 over concerns linking the additive to cancer and behavioral problems in children.
12h
on MSN
What is Duloxetine? Antidepressant Drug Recalled by FDA
Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...
Rutgers University
8h
Why the FDA Should Move Fast to Regulate Nicotine Pouches
In a commentary published in JAMA, experts at the Rutgers Institute for Nicotine & Tobacco Studies have issued a call to ...
STAT
12h
Uniqure gets FDA OK to seek accelerated approval
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
8h
Gene therapy developer's stock doubles after FDA grants accelerated approval
The FDA will allow uniQure NV to seek accelerated approval for its Huntington’s disease gene therapy more than doubled the ...
FierceBiotech
8h
Artivion nets FDA humanitarian green light for prosthetic aortic tear implant
Artivion has secured a green light from the FDA for its stent-like implant, designed to help remodel the interior of the ...
JD Supra
7h
Stem Cell Litigation Update: FDA Won the Latest Battle, but the Future of HCT/P Enforcement Remains Unclear
On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem ...
8h
SetPoint’s neurostimulation device for rheumatoid arthritis ready for FDA review
SetPoint Medical’s vagus nerve stimulator offers another treatment option for patients who do not properly respond to ...
FierceBiotech
11h
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Trump
recall
red dye
Elon Musk
Feedback